13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001768824
Total reported value
$34.0M
$34.0M
19 檔
86.2%
During the Q2 2024 filing period, TLS Advisors LLC (CIK: 0001768824) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $34.0M across 19 reported positions.
During Q2 2024, TLS Advisors LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BHP | Bhp Group Ltd-spon Adr | Stock-Materials | 17.71% | -0.03% | +10.72% | |
| 2 | RIO | Rio Tinto Plc-spon Adr | Stock-Materials | 17.01% | -2.33% | — | |
| 3 | EQT | Eqt CORP | Stock-Energy | 13.96% | +0.72% | — | |
| 4 | META | Meta Platforms Inc-class A | Stock-Comm Services | 13.36% | +3.16% | — | |
| 5 | VALE | Vale Sa-sp Adr | Stock-Materials | 11.30% | -0.76% | +9.78% | |
| 6 | XOMA | Xoma Royalty Corporation | Stock-Other | 7.14% | -3.28% | — | |
| 7 | RRC | Range Resources CORP | Stock-Energy | 4.02% | +0.10% | — | |
| 8 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 3.22% | +1.22% | — | |
| 9 | NUE | Nucor CORP | Stock-Materials | 3.16% | — | — | |
| 10 | OABI | Omniab Inc | Stock-Other | 2.35% | +0.67% | — | |
| 11 | OVID | Ovid Therapeutics Inc | Stock-Other | 2.17% | +0.05% | -14.73% | |
| 12 | HOV | Hovnanian Enterprises-a | Stock-Other | 1.37% | +0.60% | — | |
| 13 | WY | Weyerhaeuser Co | Stock-Real Estate | 1.07% | — | — | |
| 14 | NBIS | Nebius Group N.V. | Stock-Other | 0.74% | — | — | |
| 15 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.66% | — | — | |
| 16 | EWS | Ishares Msci Singapore ETF | ETF-Other | 0.65% | +0.27% | — | |
| 17 | AEI | Alset Inc | Stock-Other | 0.05% | — | — | |
| 18 | ENZB | Enzo Biochem Inc | Stock-Other | 0.04% | — | — | |
| 19 | RVP | Retractable Technologies Inc | Stock-Other | 0.03% | — | — |
According to official SEC Form 13F filings, TLS Advisors LLC reported a total U.S. public equity portfolio value of $34.0M across 19 disclosed positions in Q2 2024.
During Q2 2024, TLS Advisors LLC's top holdings by market value included BHP (17.7%)、RIO (17.0%)、EQT (14.0%). The largest single position, BHP, represented 17.7% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BHP, RIO, EQT) accounted for 86.2% of total reported equity market value during Q2 2024.
In Q2 2024, TLS Advisors LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.